MEBAZAA, A., H. TOLPPANEN, C. MUELLER, J. LASSUS, S. DISOMMA, G. BAKSYTE, M. CECCONI, D.J. CHOI, A.C. SOLAL, M. CHRIST, J. MASIP, M. ARRIGO, S. NOUIRA, D. OJJI, F. PEACOCK, M. RICHARDS, N. SATO, K. SLIWA, Jindřich ŠPINAR, H. THIELE, M.B. YILMAZ a J. JANUZZI. Acute heart failure and cardiogenic shock: a multidisciplinary practical guidance. Intensive care medicine. NEW YORK: SPRINGER, roč. 42, č. 2, s. 147-163. ISSN 0342-4642. doi:10.1007/s00134-015-4041-5. 2016.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Acute heart failure and cardiogenic shock: a multidisciplinary practical guidance
Autoři MEBAZAA, A. (250 Francie), H. TOLPPANEN (246 Finsko), C. MUELLER (756 Švýcarsko), J. LASSUS (246 Finsko), S. DISOMMA (380 Itálie), G. BAKSYTE (440 Litva), M. CECCONI (826 Velká Británie a Severní Irsko), D.J. CHOI (410 Korejská republika), A.C. SOLAL (250 Francie), M. CHRIST (276 Německo), J. MASIP (724 Španělsko), M. ARRIGO (250 Francie), S. NOUIRA (788 Tunisko), D. OJJI (566 Nigérie), F. PEACOCK (840 Spojené státy), M. RICHARDS (554 Nový Zéland), N. SATO (392 Japonsko), K. SLIWA (710 Jižní Afrika), Jindřich ŠPINAR (203 Česká republika, garant, domácí), H. THIELE (276 Německo), M.B. YILMAZ (792 Turecko) a J. JANUZZI (840 Spojené státy).
Vydání Intensive care medicine, NEW YORK, SPRINGER, 2016, 0342-4642.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30201 Cardiac and Cardiovascular systems
Stát vydavatele Spojené státy
Utajení není předmětem státního či obchodního tajemství
Impakt faktor Impact factor: 12.015
Kód RIV RIV/00216224:14110/16:00090652
Organizační jednotka Lékařská fakulta
Doi http://dx.doi.org/10.1007/s00134-015-4041-5
UT WoS 000368722000002
Klíčová slova anglicky Heart failure; Cardiogenic shock; Emergency; Treatment
Štítky EL OK
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Soňa Böhmová, učo 232884. Změněno: 29. 8. 2016 16:51.
Anotace
Purpose: Acute heart failure (AHF) causes high burden of mortality, morbidity, and repeated hospitalizations worldwide. This guidance paper describes the tailored treatment approaches of different clinical scenarios of AHF and CS, focusing on the needs of professionals working in intensive care settings. Results: Tissue congestion and hypoperfusion are the two leading mechanisms of end-organ injury and dysfunction, which are associated with worse outcome in AHF. Diagnosis of AHF is based on clinical assessment, measurement of natriuretic peptides, and imaging modalities. Simultaneously, emphasis should be given in rapidly identifying the underlying trigger of AHF and assessing severity of AHF, as well as in recognizing end-organ injuries. Early initiation of effective treatment is associated with superior outcomes. Oxygen, diuretics, and vasodilators are the key therapies for the initial treatment of AHF. In case of respiratory distress, non-invasive ventilation with pressure support should be promptly started. In patients with severe forms of AHF with cardiogenic shock (CS), inotropes are recommended to achieve hemodynamic stability and restore tissue perfusion. In refractory CS, when hemodynamic stabilization is not achieved, the use of mechanical support with assist devices should be considered early, before the development of irreversible end-organ injuries. Conclusion: A multidisciplinary approach along the entire patient journey from pre-hospital care to hospital discharge is needed to ensure early recognition, risk stratification, and the benefit of available therapies. Medical management should be planned according to the underlying mechanisms of various clinical scenarios of AHF.
VytisknoutZobrazeno: 19. 4. 2024 00:17